Algernon Pharmaceuticals Inc. reported earnings results for the first quarter ended November 30, 2023. For the first quarter, the company reported net loss was CAD 0.521554 million compared to CAD 1.88 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.2 a year ago.